| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.26 | 0.08 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.09 |